MarketPulse

autoimmune diseases

24 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Nkarta to Present at Two Major Healthcare Investment Conferences in March

Nkarta to present at two major healthcare investor conferences in March 2026, showcasing updates on its engineered NK cell therapy pipeline for autoimmune diseases.
NKTXNK cell therapiesautoimmune diseases
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Kyverna Bolsters Board With Beam, Karuna Executives Ahead of Cell Therapy Launch

Kyverna appoints two biotech executives to its board ahead of cell therapy commercialization. New directors bring expertise from Beam Therapeutics and Karuna Therapeutics.
BMYCELGrKYTXBEAMclinical developmentautoimmune diseases
GlobeNewswire Inc.GlobeNewswire Inc.··Artiva Biotherapeutics, Inc.

Artiva Biotherapeutics Names Veteran Pharma Executive Huston as CFO

Artiva Biotherapeutics appoints veteran pharma executive Thad Huston as CFO with 30+ years experience, ahead of key FDA feedback and clinical data milestones.
ARTVrestricted stock unitsautoimmune diseases
The Motley FoolThe Motley Fool··Matthew Benjamin

Eli Lilly Acquires Orna Therapeutics for $2.4B to Expand Gene Therapy Pipeline

Eli Lilly acquires Orna Therapeutics for $2.4B to gain circular RNA gene therapy technology and autoimmune disease candidates, strengthening its pipeline.
MRKLLYacquisitionclinical trials